Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 72205-031

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 72205-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Decitabine Carton Label)

Packaging label for Decitabine for Injection 50 mg per vial, a lyophilized powder for intravenous infusion by Novadoz Pharmaceuticals LLC. The label includes dosing and reconstitution instructions, warnings for cytotoxic agent, single-dose vial usage, storage conditions, and manufacturer details. The product NDC is 72205-031.*

FDA Label Image

Vial-label (Decitabine Vial Label)

Decitabine for Injection 50 mg per vial powder label for intravenous infusion. The label includes dosage and storage information, warnings about cytotoxicity, manufacturer details (MSN Laboratories Pvt Ltd, India), and distributor (Novadoz Pharmaceuticals LLC). The label also shows the NDC 72205-031-01 and a barcode.*

FDA Label Image

Structure (Structure)

Chemical structure of Decitabine, showing the molecular arrangement with an amino group, nitrogen atoms in a ring, hydroxyl groups, and a five-membered sugar ring characteristic of the nucleoside structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.